Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders

Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders

US Patent 12129484 · Granted Oct 29, 2024

Estimated economic value: $6,158,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating or inhibiting onset of Huntington's disease2025
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatm2025
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatm2025
Treating myelin diseases with optimized cell preparations2024
Muscle cell patches and uses therefor2024
Three dimensional tissue compositions and methods of use2024
Compositions and methods for improving cardiac function2023
Methods of treating neuropsychiatric disorders2023
Non-human mammal model of human degenerative disorder, uses thereof, and method 2023
Treating myelin diseases with optimized cell preparations2022
Muscle cell patches and uses therefor2021
Cardiac electrophysiologic mapping and stimulation2020